← Leaderboards
Hua Zhu
Ohio State University
$6,731,822
Attributed
$12,521,995
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,521,995 · 8
By mechanism
R01$9,033,316 · 6
U01$3,055,554 · 1
R21$433,125 · 1
Top collaborators
- Heather Chandler11 shared
- Jianjie Ma8 shared
- Ki Ho Park4 shared
- Jingsong Zhou4 shared
- Zhiwei Hu1 shared
- Zhenguo Liu1 shared
Most similar at Ohio State University
Same institution · by research overlap
- Heather Chandler$2,907,094
- Brad H Rovin$10,724,088
- Sylvester M Black$3,213,105
- Jennifer Morgan Petrosino$282,301
- Mahmood Khan$4,559,327
Others in their field
Top investigators on “Injury”
- Polly Chang · Sri International$119,352,977
- Marco Pahor · Wake Forest University Health Sciences$82,312,292
- Kerry J Kelly · New York City Fire Department$81,924,266
- Asrar B. Malik · University Of Illinois At Chicago$81,164,529
- Peter Scott Heeger · Case Western Reserve University$76,259,223
- Jacqueline Moline · Icahn School Of Medicine At Mount Sinai$75,762,106
Research focus
InjuryIn VivoProtein FamilyProteinsAnimal ModelRecombinantsStressMediatingMolecularRepairedLive Cell ImagingMouse ModelMemberGenesWound HealingTransgenic MiceIn VitroTissuesCell MembraneHomeostasisMembraneMutagenesisBiochemicalPlay
Grant awards (26)
First Aid Medicine to Treat Vesicant Induced Corneal Injury$745,148
U01 · FY2025 · EY
MG53 function in muscle aging$604,073
R01 · FY2025 · AG
Inhibiting Corneal Neovascularization by Targeting Tissue Factor$433,125
R21 · FY2025 · EY · contact PI
First Aid Medicine to Treat Vesicant Induced Corneal Injury$748,115
U01 · FY2024 · EY
MG53 function in muscle aging$617,042
R01 · FY2024 · AG
Inhibiting neovascularization for corneal wound healing$410,001
R01 · FY2024 · EY · contact PI
First Aid Medicine to Treat Vesicant Induced Corneal Injury$781,841
U01 · FY2023 · EY
MG53 function in muscle aging$617,673
R01 · FY2023 · AG
Inhibiting neovascularization for corneal wound healing$410,000
R01 · FY2023 · EY · contact PI
Inhibiting Cell Death for Protecting Cardiac Injury$390,000
R01 · FY2023 · HL · contact PI
First Aid Medicine to Treat Vesicant Induced Corneal Injury$780,450
U01 · FY2022 · EY
MG53 function in muscle aging$649,040
R01 · FY2022 · AG
Inhibiting neovascularization for corneal wound healing$410,001
R01 · FY2022 · EY · contact PI
Preservation of Limbal Stem Cell Function in Corneal Injury$397,699
R01 · FY2022 · EY · contact PI
Inhibiting Cell Death for Protecting Cardiac Injury$390,000
R01 · FY2022 · HL · contact PI
Preservation of Limbal Stem Cell Function in Corneal Injury$397,699
R01 · FY2021 · EY · contact PI
Inhibiting Cell Death for Protecting Cardiac Injury$390,000
R01 · FY2021 · HL · contact PI
Preservation of Limbal Stem Cell Function in Corneal Injury$410,000
R01 · FY2020 · EY · contact PI
Inhibiting Cell Death for Protecting Cardiac Injury$390,000
R01 · FY2020 · HL · contact PI
Regulation of Mitsugumin 29 expression in muscle physiology and diseases$327,620
R01 · FY2020 · AR · contact PI
Preservation of Limbal Stem Cell Function in Corneal Injury$410,000
R01 · FY2019 · EY · contact PI
Regulation of Mitsugumin 29 expression in muscle physiology and diseases$328,253
R01 · FY2019 · AR · contact PI
Oxidized Low-density Lipoprotein Impairs Bone Marrow Stem Cell Survival$496,008
R01 · FY2018 · HL · contact PI
Regulation of Mitsugumin 29 expression in muscle physiology and diseases$328,850
R01 · FY2018 · AR · contact PI
Regulation of Mitsugumin 29 expression in muscle physiology and diseases$329,413
R01 · FY2017 · AR · contact PI
Regulation of Mitsugumin 29 expression in muscle physiology and diseases$329,944
R01 · FY2016 · AR · contact PI